{"id":"W4403251516","doi":"10.1016/j.ygyno.2024.07.020","title":"Patient-reported outcomes from the phase III, randomized, double-blind, placebo-controlled ENGOT-cx11/GOG-3047/KEYNOTE-A18 Study of pembrolizumab plus concurrent chemoradiotherapy among patients with high-risk, locally advanced cervical cancer","year":2024,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pembrolizumab; Placebo; Chemoradiotherapy; Oncology; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002768782,0.001795671,0.003079845,0.0004434655,0.0005750569,0.0008883523,0.0008732521,0.001753932,0.005213236],"category_scores_gemma":[0.002441274,0.0005852319,0.002993163,0.000475068,0.001074792,0.001135842,0.0004163119,0.003740456,0.0006689809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000786518,"about_ca_system_score_gemma":0.001026249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001254452,"about_ca_topic_score_gemma":0.002825612,"domain_scores_codex":[0.9990522,0.0005173095,0.00007202102,0.0001543721,0.00007702242,0.000126989],"domain_scores_gemma":[0.9986744,0.0004782239,0.0003621243,0.00009781614,0.0001026219,0.0002847974],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9686363,0.005926962,0.001256753,0.00117011,0.003681825,0.00003221382,0.0000475754,0.0005101952,0.002643838,0.00007218193,0.001019884,0.01500234],"study_design_scores_gemma":[0.9311259,0.05894402,0.005597735,0.00004964176,0.00275939,0.00003876719,0.00002983473,0.0003087963,0.0004649474,0.0001014468,0.0005586944,0.00002069572],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763986,0.01122392,0.001099405,0.000810903,0.0005201718,0.003370684,0.003578774,0.0001253571,0.002872164],"genre_scores_gemma":[0.9868864,0.004010437,0.001198771,0.001035459,0.0003770436,0.002255887,0.002445771,0.00002709996,0.001763058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005213236,"threshold_uncertainty_score":0.01744002,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01930503781692493,"score_gpt":0.3229214523200555,"score_spread":0.3036164145031305,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}